Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study
- PMID: 37322426
- PMCID: PMC10267548
- DOI: 10.1186/s12879-023-08395-6
Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study
Abstract
Background: Non-conversion of sputum smear prolongs the infectivity of pulmonary tuberculosis patients and has been associated with unfavorable tuberculosis (TB) treatment outcomes. Nevertheless, there is a limited evidence on predictors of sputum smear non-conversion among smear-positive PTB (SPPTB) patients in Rwanda. Therefore, this study aimed to determine the factors associated with sputum smear non-conversion after two months of treatment among SPPTB patients in Rwanda.
Methods: A cross-sectional study was conducted among SPPTB patients registered in the national electronic TB reporting system by all health facilities countrywide (Rwanda) from July 2019 to June 2021. Eligible patients who had completed the first two months of anti-TB treatment and with smear results at the end of the second month of treatment were included in the study. Bivariate and multivariate logistic regression analyses were done using STATA version 16 to determine the factors associated with sputum smear non-conversion. Adjusted odds ratio (OR), 95% confidence interval (CI), and p-value < 0.05 was considered statistically significant.
Results: This study included 7,211 patients. Of them, 632 (9%) patients had sputum smear non-conversion at the end of the second month of treatment. In multivariate logistic regression analysis, age groups of 20-39 years (AOR = 1.7, 95% CI: 1.0-2.8) and 40-59 years (AOR:2, 95% CI: 1.1-3.3), history of first-line TB treatment failure (AOR = 2, 95% CI: 1.1-3.6), follow-up by community health workers(CHWs) (AOR = 1.2, 95% CI: 1.0-1.5), BMI < 18.5 at TB treatment initiation (AOR = 1.5, 95% CI: 1.2-1.8), and living in Northern Province of Rwanda (AOR = 1.4, 95% CI: 1.0-2.0), were found to be significantly associated with sputum smear non-conversion after two months of treatment.
Conclusion: Sputum smear non-conversion among SPPTB patients remains low in Rwanda compared to countries of similar health care setting. Identified risk factors for sputum smear non-conversion among SPPTB patients in Rwanda were age (20-39 years, 40-59 years), history of first-line TB treatment failure, follow up by CHWs, BMI < 18.5 at TB treatment initiation and residence (Northern province).
Keywords: Factors; Rwanda; Sputum non-conversion; Tuberculosis.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Predictors of delayed sputum smear conversion among pulmonary tuberculosis patients in Kota Kinabalu, Malaysia: A retrospective cohort study.Medicine (Baltimore). 2021 Aug 6;100(31):e26841. doi: 10.1097/MD.0000000000026841. Medicine (Baltimore). 2021. PMID: 34397855 Free PMC article.
-
Adherence to tuberculosis treatment, sputum smear conversion and mortality: a retrospective cohort study in 48 Rwandan clinics.PLoS One. 2013 Sep 16;8(9):e73501. doi: 10.1371/journal.pone.0073501. eCollection 2013. PLoS One. 2013. PMID: 24066053 Free PMC article.
-
Sputum smear conversion and associated factors among smear-positive pulmonary tuberculosis patients in East Gojjam Zone, Northwest Ethiopia: a longitudinal study.BMC Pulm Med. 2021 Apr 8;21(1):118. doi: 10.1186/s12890-021-01483-w. BMC Pulm Med. 2021. PMID: 33832466 Free PMC article.
-
Dynamics of sputum conversion during effective tuberculosis treatment: A systematic review and meta-analysis.PLoS Med. 2021 Apr 26;18(4):e1003566. doi: 10.1371/journal.pmed.1003566. eCollection 2021 Apr. PLoS Med. 2021. PMID: 33901173 Free PMC article.
-
Time to sputum culture conversion and its associated factors among drug-resistant tuberculosis patients: a systematic review and meta-analysis.BMC Infect Dis. 2024 Feb 7;24(1):169. doi: 10.1186/s12879-024-09009-5. BMC Infect Dis. 2024. PMID: 38326758 Free PMC article.
References
-
- Mohd Anwar LPY, Salmiah SA. M. S., S. M. Saliluddin and Doctor, “actors delaying sputum conversion in smear positive pulmonary tuberculosis: a systematic,” Int. J. Public Heal. Clin. Sci, vol. 5, no. 3, 2018, [Online]. Available: https://1library.net/document/zxv7orlv-factors-delaying-sputum-conversio...
-
- WHO., “Global tuberculosis report 2020,” 2020. [Online]. Available: 10.1016/j.ijid.2022.03.011
-
- Kayigamba FR, Bakker MI, Mugisha V, Gasana M, Van Der Loeff MFS. “Sputum completion and conversion rates after intensive phase of tuberculosis treatment: an assessment of the Rwandan control program,” 2012, [Online]. Available: https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/1756-0500-5-357.pdf - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical